Skip to main content
. 2004 Jul 19;142(8):1325–1331. doi: 10.1038/sj.bjp.0705885

Figure 1.

Figure 1

Inhibition of 10 μM ADP-induced platelet activation by AR-C69931MX in (a) and MRS2179 in (b) compared with different combinations of AR-C69931MX and MRS2179, expressed as a percentage of PAC-1 MFI in the absence of antagonist. Data represents mean values of five separate experiments.